Historical record - last NADAC publication: 3/20/2019
Product Information
AMLODIPINE-VALSARTAN 5-160 MG is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.3923 per EA under NDC 43386008309. Its NADAC has been published 191 times since Aug 12, 2015.
The High Outlier badge above means this manufacturer's average price in the Amlodipine and Valsartan market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5; 160 mg/1; mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
43386008309
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
3/20/2019
Active Ingredients
AMLODIPINE BESYLATE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA202829On Market Since
3/30/2015
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-VALSARTAN 5-160 MG has been published 191 times since Aug 12, 2015, and over the history we have for it it has declined 30.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3923 per EA |
|---|---|
| All-time high | $0.6130 (Oct 14, 2015) |
| All-time low | $0.3625 (Dec 19, 2018) |
| Median price | $0.4577 |
| Average price | $0.4630 |
| Largest weekly change | -20.2% (Jan 18, 2017) |
| Weeks tracked | 191 |
| Tracking since | Aug 12, 2015 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of AMLODIPINE-VALSARTAN 5-160 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-VALSARTAN 5-160 MG, manufactured by Lupin Pharmaceuticals Inc., is $0.3923 per EA (NDC 43386008309), effective Apr 3, 2019.
How has the price of AMLODIPINE-VALSARTAN 5-160 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has declined 30.4%. It has been tracked across 191 weekly CMS publications since Aug 12, 2015.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-VALSARTAN 5-160 MG?
Since Aug 12, 2015, the NADAC for AMLODIPINE-VALSARTAN 5-160 MG has ranged from a low of $0.3625 (Dec 19, 2018) to a high of $0.6130 (Oct 14, 2015), with a median of $0.4577 per EA.
Are there cheaper alternatives to AMLODIPINE-VALSARTAN 5-160 MG?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, AMLODIPINE-VALSARTAN 5-160 MG, is $0.3721 per EA — about 5% below AMLODIPINE-VALSARTAN 5-160 MG.
Who manufactures AMLODIPINE-VALSARTAN 5-160 MG?
AMLODIPINE-VALSARTAN 5-160 MG (NDC 43386008309) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification